​​Evvy expands precision women’s health with at-home UTI+ Test

Evvy, the precision women’s health company known for its vaginal microbiome test, has launched UTI+, an at-home urine test that uses PCR technology to detect 12 key uropathogens and 7 antibiotic resistance markers — delivering lab-grade results in just one business day.

Fixing outdated UTI care

According to data provided by the brand, UTIs are the most common infection in U.S. women. Yet, standard urine cultures miss up to 60–70% of pathogens and can take days to return results. That lag often leads to trial-and-error prescribing and recurring infections.

Evvy’s UTI+ Test addresses those gaps by identifying the exact bacteria causing infection and, if eligible, connecting users to same-day, targeted prescription treatment.

How it works

After you collect your urine sample and mail it to Evvy’s CLIA-certified lab, results are ready within one business day. Eligible users can then receive same-day, targeted prescription treatment based on their results, eliminating the guesswork that often comes with standard urine cultures.

The next layer of women’s health data

For those with recurring UTIs, Evvy’s vaginal microbiome test can provide additional insight. The company’s data shows that 47% of users who reported a recent UTI had UTI-related bacteria detected in their vaginal microbiome — suggesting a connection between vaginal health and urinary health.

The launch of UTI+ expands Evvy’s platform to cover vaginal microbiome, UTI, and STI testing — plus personalized prescription care and 1:1 coaching — bringing more precise, connected solutions to women’s health.

Where to buy

The Evvy UTI+ Test is available now at evvy.com for $248 or $218 with a subscription (available in the U.S., except AK, HI, and NY).